Citation: Dw. Stacey et al., Influence of cell cycle and oncogene activity upon topoisomerase II alpha expression and drug toxicity, MOL CELL B, 20(24), 2000, pp. 9127-9137
Citation: M. Hitomi et Dw. Stacey, Cyclin D1 production in cycling cells depends on Ras in a cell-cycle-specific manner, CURR BIOL, 9(19), 1999, pp. 1075-1084
Authors:
Chen, G
Templeton, D
Suttle, DP
Stacey, DW
Citation: G. Chen et al., Ras stimulates DNA topoisomerase II alpha through MEK: A link between oncogenic signaling and a therapeutic target, ONCOGENE, 18(50), 1999, pp. 7149-7160
Authors:
Stacey, DW
Hitomi, M
Kanovsky, M
Gan, L
Johnson, EM
Citation: Dw. Stacey et al., Cell cycle arrest and morphological alterations following microinjection of NIH3T3 cells with Pura alpha, ONCOGENE, 18(29), 1999, pp. 4254-4261
Citation: M. Hitomi et Dw. Stacey, Cellular ras and cyclin D1 are required during different cell cycle periods in cycling NIH 3T3 cells, MOL CELL B, 19(7), 1999, pp. 4623-4632
Authors:
Shu, JY
Harwalkar, JA
Oh-Siskovic, S
Stacey, DW
Golubic, M
Citation: Jy. Shu et al., Adenovirus-mediated gene transfer of dominant negative Ha-Ras inhibits proliferation of primary meningioma cells, NEUROSURGER, 44(3), 1999, pp. 579-587